At SDS Life Science, we know that many drug development projects fail due to either running out of time or funding, not being adequately prepared before interacting with the authorities, or due to study design-related mistakes. Not because the idea itself is scientifically bad. It’s probably not.
Contact a consultant
Are you doing the right things at the right time?
Imagine this. You’re at the top of the game regarding the details and science behind the drug itself. Now, without doing the right things at the right time, your project might be at risk of not gaining regulatory approval. At the end of the day, patients will not receive the help they need in the form of your intended treatment. Or they will not receive it in time. This is where we help.
Services that get you closer to market approval
Our services within regulatory affairs ensure an increased chance of reaching market approval while avoiding unnecessary delays. We evaluate any opportunities for ‘’expedited pathways’’, a technical term for various regulatory fast-tracking possibilities intended to reduce time to market significantly.